Board certification such as a DABT is an advantage.Īt Roche, more than 100,000 people across 100 countries are pushing back the frontiers of healthcare.Good knowledge and experience of immunology is a plus. Pathology qualification or experience is preferred.Good knowledge of toxicology including common early safety screening strategy and technology and animal care and welfare principles.Good organizational and multi-tasking abilities.Strong interpersonal skills and team player.Good English communication and presentation skills.You have a DVM, PhD or equivalent and >1 year of post-doc/working experience in relevant toxicology areas.Expand scientific visibility and maintain effective interactions with internal and external collaborators, and contribute to scientific advancements in the toxicology field.Embrace innovation and utilize emerging technologies to support risk assessments.Aim for scientific excellence and extraordinary results as well as prioritize and manage high expectations in a fast-paced environment.

Generating concise safety assessments for internal decision making, accountable for result analysis and interpretation, trouble shooting, as well as contributing to protocol/report of safety studies and related documentation.Representing non-clinical safety on collaborations with external partners including CROs.Support late stage development in China as an expert toxicologist for review of dossiers and interaction with the NMPA for global Roche submissions for all disease areas and modalities applicable for NMPA submissions.Representing the toxicology function on multi-functional project teams and acting as a key contributor to the selection and development of potential new medicines through close interactions with other functions such as DMPK, biology, CMC and clinical development.Leading global non-clinical Expert Teamsto maximize the impact on portfolio projects and development of unique/tailored nonclinical strategies to support the portfolio and to lead efforts of investigating mechanisms of toxicity of drug candidates.Developing and executing high quality, timely, integrated and scientifically sound nonclinical safety strategies from target assessment through discovery and early development.This group leads in the development of the non-clinical safety assessment of drug candidates during the discovery and development phases at Roche. The position is within the global Toxicology Project Leaders (TPL) group in Pharmaceutical Sciences (PS) and located at Roche Innovation Center Shanghai (RICS).

Target presentation expert salary